Sinclair Pharma logo

SPH - Sinclair Pharma Share Price

31.8p 0.0  0.0%

Last Trade - 02/11/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £50.6m
Position in Universe th / 1809
Bullish
Bearish
Unlock SPH Revenue
Momentum
Relative Strength (%)
1m -1.33%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
55.4 63.6 27.8 45.5 45.3 50.6 72.7 95.0 -1.8%
+100.0
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019, SinclairPharma Ltd revenues totaled £50.6M. Net income beforeextraordinary items totaled to £2.9M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

SPH Revenue Unlock SPH Revenue

Net Income

SPH Net Income Unlock SPH Revenue

Normalised EPS

SPH Normalised EPS Unlock SPH Revenue

PE Ratio Range

SPH PE Ratio Range Unlock SPH Revenue

Dividend Yield Range

SPH Dividend Yield Range Unlock SPH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
SPH EPS Forecasts Unlock SPH Revenue
Profile Summary

Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor. The Company's product categories include Aesthetic Care, Skin Care, Wound Care and Non-Dermatology. The Company provides aesthetic dermatology solutions through thread lift, collagen stimulation and dermal fillers. The Company's aesthetic products include Silhouette Soft, Ellanse, Perfectha, Sculptra and USOFT Massage Gel. Its Silhouette Soft is inserted in the subcutaneous tissue. Its USOFT Massage Gel is a gel used for facial massage. It is engaged in research and development, and owns various product rights and licenses in a range of territories in which it trades.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2018
Incorporated July 29, 1999
Public Since December 11, 2003
No. of Shareholders: n/a
No. of Employees: 275
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange London Stock Exchange
Shares in Issue 580,157,084
Free Float (0.0%)
Eligible for
ISAs
SIPPs
SPH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for SPH
Upcoming Events for SPH
Frequently Asked Questions for Sinclair Pharma
What is the Sinclair Pharma share price?

As of 02/11/18, shares in Sinclair Pharma are trading at 31.8p, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Sinclair Pharma share price performed this year?

Shares in Sinclair Pharma are currently trading at 31.8p and the price has moved by 10.13% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sinclair Pharma price has moved by 4.58% over the past year.

What are the analyst and broker recommendations for Sinclair Pharma?

Of the analysts with advisory recommendations for Sinclair Pharma, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Sinclair Pharma is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Sinclair Pharma next release its financial results?

Sinclair Pharma is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-06-30
What is the Sinclair Pharma dividend yield?

Sinclair Pharma does not currently pay a dividend.

Does Sinclair Pharma pay a dividend?

Sinclair Pharma does not currently pay a dividend.

When does Sinclair Pharma next pay dividends?

Sinclair Pharma does not currently pay a dividend.

How do I buy Sinclair Pharma shares?

To buy shares in Sinclair Pharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Sinclair Pharma?

Shares in Sinclair Pharma are currently trading at 31.8p, giving the company a market capitalisation of £n/a.

Where are Sinclair Pharma shares listed? Where are Sinclair Pharma shares listed?

Here are the trading details for Sinclair Pharma:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: SPH
What kind of share is Sinclair Pharma?

We were not able to load our ranking data for Sinclair Pharma

Is there a Sinclair Pharma share price forecast 2021?

We were not able to load any forecast data for Sinclair Pharma.

How can I tell whether the Sinclair Pharma share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sinclair Pharma. Over the past six months, the relative strength of its shares against the market has been 78.81%. At the current price of 31.8p, shares in Sinclair Pharma are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Sinclair Pharma PE Ratio?

We were not able to find PE ratio data for Sinclair Pharma.

Who are the key directors of Sinclair Pharma?

Sinclair Pharma's management team is headed by:

Grahame Cook - NEC
Alan Olby - CFO
Jean-Charles Tschudin - NID
Christopher Spooner - CEO
Jean-Louis Lamande - FID
Patrick Khoukaz - OTH
Sarb Klair - OTH
Nairn McMaster - OTH
Jayne Burrell - GCN
Allyson Meyers - VPR
Who are the major shareholders of Sinclair Pharma?

Here are the top five shareholders of Sinclair Pharma based on the size of their shareholding:

Similar to SPH
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.